SOHO 2022 Tenth Annual Meeting
Playback speed
10 seconds
SOHO 2022: Pivotal Results From a Phase I/II Study of Mosunetuzumab Monotherapy for Patients With R/R FL Who Have Received ≥2 Prior Lines of Therapy
By
SOHO 2022 Tenth Annual Meeting
FEATURING
Loretta Nastoupil
By
SOHO 2022 Tenth Annual Meeting
FEATURING
Loretta Nastoupil
33 views
October 14, 2022
Login to view comments.
Click here to Login
Lymphoma